Adicet Bio (ACET) Earnings Date & Reports

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases... Show more

Industry: #Medical Distributors

Get AI intraday signals

A.I. Advisor

published Earnings

ACET is expected to report earnings to rise 4.37% to -33 cents per share on May 20

Q1'25

Est.

$-0.33

Q4'24

Beat

by $0.03

Q3'24

Est.

$-0.34

Q2'24

Beat

by $0.03

Q1'24

Beat

by $0.10

The last earnings report on March 06 showed earnings per share of -31 cents, beating the estimate of -34 cents. With 303.46K shares outstanding, the current market capitalization sits at 59.86M.

View a ticker or compare two or three

Compare

ACET